ConductScience.org, home

Library / Genes

CCR3: C-C motif chemokine receptor 3

1 protein, 136 patents, 0 drugs, 0 trials, 3,197 NIH grants and 5,066 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCCR3HGNC
NameC-C motif chemokine receptor 3HGNC
NCBI Gene ID1232NCBI Gene
HGNC IDHGNC:1604HGNC
EnsemblENSG00000183625NCBI Gene
AliasesC C CKR3, CC-CKR-3, CD193, CKR 3, CKR3, CMKBR3NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P51677C-C chemokine receptor type 33551Ensembl, GeneID, HGNCUniProt

Patents 136

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026170016 A12026-08-1310P51677Espacenet
EP 4724076 A22026-04-1576P51677Espacenet
JP 2026062654 A2026-04-1024P51677Espacenet
JP 2026004568 A2026-01-1441044P51677Espacenet
JP 2026004568 A2026-01-1441045P51677Espacenet
JP 2026004568 A2026-01-1441046P51677Espacenet
JP 2026004568 A2026-01-1441049P51677Espacenet
WO 2025259871 A12025-12-1820P51677Espacenet
EP 4641202 A22025-10-29402P51677Espacenet
JP 2025147176 A2025-10-0616649P51677Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3197

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
U19AI070235Epithelial Genes in Allergic Inflammation192,025NIH's project files
P30DK078392Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease152,025NIH's project files
ZIAAI001130Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease112,025NIH's project files
ZIAAI000615Molecular Analysis Of Leukocyte Activation By Chemoattractants82,025NIH's project files
U19AI095219Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease72,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award72,025NIH's project files
T32AI007290Molecular and Cellular Immunobiology62,025NIH's project files
U54CA1186381/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership62,025NIH's project files
P30ES010126UNC Center for Environmental Health and Susceptibility52,025NIH's project files
P50CA136393Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer52,025NIH's project files

Papers 5066

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42780662PubTator, text miningPubMed
42770147PubTator, text miningPubMed
42737426PubTator, text miningPubMed
42713623PubTator, text miningPubMed
42467066PubTator, text miningPubMed
42466809PubTator, text miningPubMed
42426942PubTator, text miningPubMed
42367758PubTator, text miningPubMed
42365474PubTator, text miningPubMed
42318335PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license